TBA The Biotechnology Initiative

The Voice of Bioscience in Ontario

NEWS

SPONSORS

Flash Slideshow

 


Immunovaccine Inc. is partnering and collaborating with organizations to make better vaccines

Immunovaccine Inc. is partnering and collaborating with organizations to make better vaccines. On November 10th Immunovaccine announced the signing of a new collaborative agreement with the National Cancer Institute (NCI) in Maryland, USA to assist in development of cancer vaccines by formulating NCI’s antigens in the DepoVax™ vaccine enhancement technology. On October 29 Immunovaccine announced the expansion of its collaboration agreement with Department of Research and Defence Canada (DRDC) to develop anthrax and Glanders vaccines. To view the releases, please click on the links below.

Click here for "Press Release 1"

Click here for "Press Release 2"

RSS feed is now available for Immunovaccine’s press releases. Please sign up at www.imvaccine.com. We are pleased to be working with so many stellar organizations to deliver breakthrough vaccines.